SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001062993-24-008564
Filing Date
2024-04-19
Accepted
2024-04-19 06:01:49
Documents
16
Period of Report
2024-04-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K form8k.htm   iXBRL 8-K 17177
2 EXHIBIT 10.1 exhibit10-1.htm EX-10.1 273595
  Complete submission text file 0001062993-24-008564.txt   574466

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT flgc-20240416.xsd EX-101.SCH 4687
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT flgc-20240416_cal.xml EX-101.CAL 698
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT flgc-20240416_def.xml EX-101.DEF 22562
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT flgc-20240416_lab.xml EX-101.LAB 47263
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT flgc-20240416_pre.xml EX-101.PRE 25251
20 EXTRACTED XBRL INSTANCE DOCUMENT form8k_htm.xml XML 3278
Mailing Address 3406 SW 26TH TERRACE, SUITE C-1 FORT LAUDERDALE FL 33312
Business Address 3406 SW 26TH TERRACE, SUITE C-1 FORT LAUDERDALE FL 33312 416-861-2267
Flora Growth Corp. (Filer) CIK: 0001790169 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40397 | Film No.: 24855518
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)